We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Human ORF Clones Available to Scientists

By Biotechdaily staff writers
Posted on 09 Jul 2002
More than 8,000 human open reading frame (ORF) clones from full-length genes have been released to the scientific community, derived from a collection of highly curated and verified human full-length cDNAs.

The entire collection, called ORFexpress, has been cloned into a vector system compatible with the Gateway technology of Invitrogen Corp. This allows rapid and simple transfer of the coding ORFs into a whole suite of Gateway destination vectors, as well as transfer of ORFs into other expression vectors via restriction and ligation--significantly facilitating the expression and functional analyses of target proteins and shortening drug discovery time. The collection was assembled by GeneCopoeia, Inc. (Frederick, MD, USA). The clones are available on the company's website for the internal research purposes of scientists.

"The release of these clones to the scientific community makes finding a high quality gene in a ready-to-use format as easy as clicking your mouse,” said Shuwei Yang, president of GeneCopoeia. "We are continuing to add new clones every week and will also begin work on other model organisms such as mouse and other pathogenic organisms.”




Related Links:
GeneCopoeia

Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Pipette Calibration System
Artel PCS®

Latest BioResearch News

New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer
09 Jul 2002  |   BioResearch

Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
09 Jul 2002  |   BioResearch

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
09 Jul 2002  |   BioResearch



ADLM